Marion R Wofford,Deborah S King,T Kristopher Harrell
Marion R Wofford
The metabolic syndrome is a cluster of risk factors associated with an increased risk for cardiovascular disease and type 2 diabetes. Based on data from 1988 to 1994, it is estimated that 24% of adults in the United States meet the criteria...
Management strategies for patients with hypertension and diabetes: why combination therapy is critical [0.03%]
高血压合并糖尿病患者的管理策略——联合治疗为何如此关键
Sara Giunti,Mark Cooper
Sara Giunti
Hypertension is commonly associated and acts synergistically with diabetes in increasing the risk of macrovascular and microvascular diabetic complications. Large-scale clinical trials have demonstrated that this risk is significantly reduc...
Providing end-organ protection with renin-angiotensin system inhibition: the evidence so far [0.03%]
肾素血管紧张素系统抑制的器官保护作用：迄今证据综述
Matthew R Weir
Matthew R Weir
Much debate surrounds the question of the optimal therapeutic choices for medication to control blood pressure and reduce cardiovascular events. Experimental evidence suggests that drugs that block the renin-angiotensin system retard vascul...
Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002 [0.03%]
2001～2002年美国高血压患病率、知晓率、治疗率和控制率：美国国家健康与营养调查（NHANES）结果
Bernard M Y Cheung,Kwok Leung Ong,Yu Bun Man et al.
Bernard M Y Cheung et al.
The prevalence, awareness, treatment, and control of hypertension in the United States are analyzed using the National Health and Nutrition Examination Survey (NHANES) database covering the period 1988-2002. Mean body mass index was 26.1+/-...
Vasilios Papademetriou
Vasilios Papademetriou
Building on the specialist's antihypertensive treatment recommendation: it's just the beginning [0.03%]
遵从高血压专病医师治疗推荐：这只是个开始
Elijah Saunders
Elijah Saunders
Patients with established cardiovascular disease are a top priority for preventive medicine. Evidence from clinical trials supports the merits of aggressive risk reduction therapies in survivors of an acute event. Improving their cardiovasc...
Hypertension-related morbidity and mortality in African Americans--why we need to do better [0.03%]
美国非裔人群中的高血压相关残疾和死亡--为何我们需要做得更好
Keith C Ferdinand,Elijah Saunders
Keith C Ferdinand
Almost one third of adults in the United States have hypertension. Prevalence data among different racial or ethnic groups indicate that a disproportionate number of African Americans have hypertension compared with non-Hispanic whites and ...
Hypertension--a treatable component of the cardiometabolic syndrome: challenges for the primary care physician [0.03%]
高血压是可治疗的代谢性心血管综合征组分之一：全科医师所面临的挑战
Camila M Manrique,Guido Lastra,John Palmer et al.
Camila M Manrique et al.
Patients with the cardiometabolic syndrome (CMS) have an adverse cardiovascular risk factor profile, placing them at increased risk of stroke, coronary artery disease, chronic kidney disease, and type 2 diabetes mellitus. Although no specif...
Elizabeth O Ofili
Elizabeth O Ofili
Data from well designed randomized trials have proven the effectiveness of an intensive approach to hypertension management in reducing morbidity and mortality. Based on these data, guidelines recommend a blood pressure goal of